The expression profile of the toll-like receptor family in scleroderma dermal fibroblasts

A Sakoguchi1, W Nakayama, M Jinnin

  • 1Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. pediatric-dr.a@canvas.ocn.ne.jp.

Abstract

Insights

Toll-like receptors (TLRs) like TLR5 and TLR10 are upregulated in systemic sclerosis (SSc) fibroblasts. TLR5 activation may suppress collagen production, potentially acting as a negative feedback mechanism against fibrosis in SSc.

Area of Science:

  • Dermatology
  • Immunology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are implicated in various skin diseases.
  • The role and expression of TLRs in systemic sclerosis (SSc) remain unclear.

Purpose of the Study:

  • To investigate TLR gene expression profiles in SSc fibroblasts.
  • To elucidate the role of TLRs in the pathogenesis of SSc.

Main Methods:

  • Gene array analysis to assess TLR-related gene expression.
  • Real-time PCR, immunoblotting, and immunohistochemistry to validate mRNA and protein levels.
  • Investigated the effect of TLR5 stimulation on collagen expression.

Main Results:

  • TLR5 and TLR10 mRNA and protein levels were significantly upregulated in SSc fibroblasts.
  • TLR expression was confirmed in SSc fibroblasts in vivo.
  • TLR5 stimulation reduced type I collagen expression in SSc fibroblasts.

Conclusions:

  • Increased TLR5 and TLR10 expression in SSc fibroblasts is likely mediated by TGF-β/Smad3 signaling.
  • TLR5 activation may suppress collagen production, potentially counteracting SSc-related fibrosis.